These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 38399953)
1. Causes and Consequences of Coronavirus Spike Protein Variability. Zech F; Jung C; Jacob T; Kirchhoff F Viruses; 2024 Jan; 16(2):. PubMed ID: 38399953 [TBL] [Abstract][Full Text] [Related]
2. An overview on the seven pathogenic human coronaviruses. Kesheh MM; Hosseini P; Soltani S; Zandi M Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073 [TBL] [Abstract][Full Text] [Related]
3. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
4. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775 [TBL] [Abstract][Full Text] [Related]
5. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM Front Immunol; 2022; 13():954093. PubMed ID: 36159791 [TBL] [Abstract][Full Text] [Related]
6. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431 [TBL] [Abstract][Full Text] [Related]
7. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167 [TBL] [Abstract][Full Text] [Related]
8. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography. Wang J; Li D; Zhou Q; Wiltse A; Zand MS Front Immunol; 2021; 12():696370. PubMed ID: 34386006 [TBL] [Abstract][Full Text] [Related]
9. Human coronaviruses: Origin, host and receptor. Tang G; Liu Z; Chen D J Clin Virol; 2022 Oct; 155():105246. PubMed ID: 35930858 [TBL] [Abstract][Full Text] [Related]
10. Coronaviruses and SARS-COV-2. Hasöksüz M; Kiliç S; Saraç F Turk J Med Sci; 2020 Apr; 50(SI-1):549-556. PubMed ID: 32293832 [TBL] [Abstract][Full Text] [Related]
11. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan. Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267 [TBL] [Abstract][Full Text] [Related]
12. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269 [TBL] [Abstract][Full Text] [Related]
13. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013 [TBL] [Abstract][Full Text] [Related]
14. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion. Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484 [TBL] [Abstract][Full Text] [Related]
15. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567 [TBL] [Abstract][Full Text] [Related]
16. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019. Zhang Y; Su L; Chen Y; Yu S; Zhang D; Mao H; Fang L Virol J; 2021 Apr; 18(1):89. PubMed ID: 33931105 [TBL] [Abstract][Full Text] [Related]
17. Overview of lethal human coronaviruses. Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062 [TBL] [Abstract][Full Text] [Related]
18. Evidence for an Ancestral Association of Human Coronavirus 229E with Bats. Corman VM; Baldwin HJ; Tateno AF; Zerbinati RM; Annan A; Owusu M; Nkrumah EE; Maganga GD; Oppong S; Adu-Sarkodie Y; Vallo P; da Silva Filho LV; Leroy EM; Thiel V; van der Hoek L; Poon LL; Tschapka M; Drosten C; Drexler JF J Virol; 2015 Dec; 89(23):11858-70. PubMed ID: 26378164 [TBL] [Abstract][Full Text] [Related]
20. Current Strategies of Antiviral Drug Discovery for COVID-19. Mei M; Tan X Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]